# Intuitive Surgical, Inc. (ISRG) FY2024 Q3 Balance Sheet

- Company: Intuitive Surgical, Inc. (ISRG)
- Period: As of 2024-09-30
- Filing: Q3 FY2024 10-Q, filed 2024-10-18, accession number 0001035267-24-000247
- Page: https://plicit.ai/financials/isrg/fy2024-q3-balance-sheet
- Chart image: https://plicit.ai/charts/isrg-fy2024-q3-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2024-09-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 17,743,400,000 US dollars
- **Current assets**: 7,215,600,000 US dollars
- **Non-current assets**: 10,527,800,000 US dollars
- **Liabilities**: 2,065,900,000 US dollars
- **Current liabilities**: 1,676,800,000 US dollars
- **Non-current liabilities**: 389,100,000 US dollars
- **Equity**: 15,677,500,000 US dollars
- **Noncontrolling interest**: 94,200,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Cash and cash equivalents**: 2,413,300,000 US dollars
- **Short-term investments**: 1,818,400,000 US dollars
- **Inventory**: 1,481,700,000 US dollars
- **Accounts receivable, net**: 1,153,000,000 US dollars
- **Prepaids and other current assets**: 349,200,000 US dollars
- **Property, plant, and equipment, net**: 4,433,000,000 US dollars
- **Long-term investments**: 4,079,800,000 US dollars
- **Deferred tax assets**: 997,000,000 US dollars
- **Intangible and other assets, net**: 669,700,000 US dollars
- **Goodwill**: 348,300,000 US dollars
- **Other accrued liabilities**: 654,600,000 US dollars
- **Deferred revenue**: 426,000,000 US dollars
- **Accrued compensation and employee benefits**: 377,500,000 US dollars
- **Accounts payable**: 218,700,000 US dollars
- **Other long-term liabilities**: 389,100,000 US dollars
- **Additional paid-in capital**: 9,440,200,000 US dollars
- **Retained earnings**: 6,129,800,000 US dollars
- **Accumulated other comprehensive income (loss)**: 12,900,000 US dollars
- **Common stock, 600.0 shares authorized, $0.001 par value, 356.2 shares and 352.3 shares issued and outstanding as of September 30, 2024, and December 31, 2023, respectively**: 400,000 US dollars
- **Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of September 30, 2024, and December 31, 2023**: 0 US dollars
- **Noncontrolling interest in joint venture**: 94,200,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.